y 27632 has been researched along with Experimental Hepatoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arihiro, K; Asahara, T; Fudaba, Y; Kobayashi, T; Miyata, Y; Ogawa, T; Okajima, M; Tashiro, H; Ushitora, Y | 1 |
Chen, XS; Han, LZ; Li, QG; Qiu, F; Xi, ZF; Xia, Q; Xue, F; Zhang, JJ; Zhang, M | 1 |
2 other study(ies) available for y 27632 and Experimental Hepatoma
Article | Year |
---|---|
Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model.
Topics: Amides; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Enzyme Inhibitors; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Liver Neoplasms, Experimental; Liver Transplantation; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred BUF; rho-Associated Kinases; Signal Transduction; Tacrolimus | 2007 |
Rho signaling inhibitor, Y-27632, inhibits invasiveness of metastastic hepatocellular carcinoma in a mouse model.
Topics: Actins; Amides; Animals; Apoptosis; Cytoskeleton; Enzyme Inhibitors; Female; Liver Neoplasms, Experimental; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Pyridines; ras Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; rhoC GTP-Binding Protein | 2007 |